Find out what’s hitting the headlines in our pioneering dementia research and how your support is bringing us closer to a cure.
If you have a press enquiry please visit our Press Office page.
Researchers at Yale School of Medicine in the US have discovered a new experimental drug which could potentially be investigated as a treatment for Alzheimer’s disease.
A new study has suggested that high blood pressure in midlife could predict cognitive decline in later life.
New research indicates that people with depressive symptoms in later life are more likely to develop dementia than those of a similar age without depression.
Newly-released figures suggest that the number of recorded cases of dementia in England has risen 62% in the last seven years.
A new study has found that people with harmful levels of alcohol consumption in mid-life are more likely to have severe cognitive problems in later life.
Research shows that improved access to education and living conditions are more beneficial to women in terms of memory and thinking skills.
Amyloid and tau are the two major proteins shown to play a role in Alzheimer’s disease. New research presented at the Alzheimer’s Association International Conference 2014 shows that the build-up of a third protein, TDP-43, may also cause memory and thinking problems.
Work presented at the Alzheimer’s Association International Conference 2014 suggests that build-up of a protein called tau in the brain, known to be a hallmark of Alzheimer’s, is associated with worsening memory score tests over time in healthy individuals.
A new study presented at the Alzheimer’s Association International Conference 2014 shows that eight sessions of psychological therapy can help reduce anxiety and depression in people caring for a family member with dementia.